The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
Pharmacology
[키워드] ACE-2 receptor
acute respiratory distress
acute respiratory syndrome
addition
alveolar
ARDS
ARDS patient
association
Cell
clinical outcomes
clinical symptom
clinical trial
Coronavirus-2
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
disease
distress
effective
Efficacy
etiology
evaluate
function
homeostasis
hydrophilic
hydrophobic
IMPROVE
Inconclusive
Infection
initiated
Lipid
lipids
lung
Lungs
microbial
Neonatal
NRDS
over
Prevent
Protein
pulmonary
Pulmonary Surfactant
reducing
replicate
Research
respiratory
Respiratory function
respiratory illnesses
responsible
role
SARS-CoV-2
SARS-CoV-2 virus
Scientific community
surfactant
syndrome
tension
Therapeutic benefit
therapeutic option
Treatment
[DOI] 10.3389/fphar.2021.698905 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.698905 PMC 바로가기 [Article Type] Pharmacology